Theravance Inc (NASDAQ:THRX)

Monday’s trading has closed, but THRX is being traded in the after-hours session. After-Hours quote »
16.60
Delayed Data
As of 4:00pm ET
 -1.33 / -7.39%
Today’s Change
10.58
Today|||52-Week Range
31.80
+17.28%
Year-to-Date
No recent news for Theravance Inc.

Today’s Trading

Previous close17.92
Today’s open17.96
Day’s range16.50 - 17.98
Volume629,293
Average volume (3 months)926,240
Market cap$2.1B
Dividend yield6.03%
Data as of 4:00pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+90.00%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.51-3.34%
ADROAduro Biotech Inc-3.94-10.94%
MNKDMannkind Corp-0.21-4.37%
INSYINSYS Therapeutics I...-6.00-9.61%
Data as of 4:00pm ET, 04/27/2015

Financials

Last reporting dateApril 27, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers